TrialCancer biology & medicine2020

Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.

Tingting Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.